Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Menlo Ventures Devotes New $500M Fund to Mid-Stage Growth Companies	Bernadette Tansey	02/20/19	San Francisco
With New Data, Intercept On Track for First-Ever Approved NASH Drug	Ben Fidler	02/19/19	New York
Bill Maris Fund Section 32 Notches Two Wins with Life Science Exits	Sarah de Crescenzo	02/15/19	San Diego
Google Confirms New Madison Office, Part of $13B National Expansion	Jeff Engel	02/15/19	Wisconsin
“Stigma is Going Away”: Cannabis IP is Thorny, But Not Impossible	Sarah Schmid Stevenson	02/15/19	Detroit Ann Arbor
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More	Alex Lash	02/15/19	National
Finding True Love Can Be Ruff, But This Startup Could Have Your Match	Angela Shah	02/14/19	National
It’s Not You, It’s Your Officials: Amazon Cancels HQ Plan for NYC	David Holley	02/14/19	New York
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again	Ben Fidler	02/14/19	National
DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead	Frank Vinluan	02/13/19	National
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B	Frank Vinluan	02/13/19	New York
Why Did Amazon Buy Eero? Wi-Fi Users Covet Simplicity, Security	Jeff Buchanan	02/12/19	Seattle
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans	Ben Fidler	02/12/19	National
May Mobility Snags $22M Investment, Will Expand to New Cities in ’19	Sarah Schmid Stevenson	02/12/19	Detroit Ann Arbor
With Low Expectations, Gilead’s Top NASH Drug Fails 1st Major Test	Alex Lash	02/11/19	San Francisco
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug	Frank Vinluan	02/11/19	San Francisco
Qualcomm Sells Medical Device Connectivity Business to PE Firm	Sarah de Crescenzo	02/11/19	San Diego
GV Taps Ex-Agios CEO Schenkein to Lead Life Science Investments	Frank Vinluan	02/11/19	San Francisco
Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60%	Ben Fidler	02/11/19	New York
Bain Capital Backs ImageMoverMD’s Medical Image Management Tools	Jeff Engel	02/08/19	Wisconsin
French Auto Supplier Valeo Moves Toward Mobility with New Innovations	Sarah Schmid Stevenson	02/08/19	Detroit Ann Arbor
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More	Ben Fidler	02/08/19	National
Gossamer Bio Adds $276M in Second Biotech “Unicorn” IPO of 2019	Sarah de Crescenzo	02/07/19	San Diego
Harpoon’s IPO Spears $76M as Prostate Cancer Drug Continues Testing	Frank Vinluan	02/07/19	San Francisco
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit	Alex Lash	02/07/19	San Francisco
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell	Ben Fidler	02/07/19	New York
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials	Frank Vinluan	02/06/19	San Francisco
New CRISPR Fight: Old Friends Intellia, Caribou in License Dispute	Alex Lash	02/06/19	San Francisco
Foot Traffic Startup Scraffic Mulls New Funding, Machine Learning	David Holley	02/06/19	Texas
Bolt Bio Bags $54M for Drugs that Turn the Heat Up on “Cold” Tumors	Frank Vinluan	02/05/19	San Francisco
Page 1 of 618	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Xconomy Insight · Special Report
Starting a Biotech Company: What Every Entrepreneur Needs to Know
Get advice from the experts to help your biotech startup succeed